Masocol, Kate Ayiesshajoy P.
HRN: 20-55-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2025
CEFUROXIME 750MG (VIAL)
01/07/2025
01/14/2025
IV
380mg
Q8hours
Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes